Back
Solid Biosciences Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
28
SLDB
Solid Biosciences
Last Price:
6.40
Seasonality Move:
34.79%
Sell
32
SRPT
Sarepta Therapeutics
Last Price:
125.95
Seasonality Move:
0.66%
Sell
28
Solid Biosciences (SLDB)
is a Sell
Is Solid Biosciences a Buy, Sell or Hold?
- The current Solid Biosciences [SLDB] share price is $7.01. The Score for SLDB is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- SLDB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $125.92. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLDB Stock Price Chart
What is Solid Biosciences's stock price today?
-
The Solid Biosciences share price today is $7.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLDB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $125.92
The current trend is relatively stagnant and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SLDB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 48.75 | Sell |
Chaikin Money Flow: | 191244 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.51 - 7.65) | Sell |
Bollinger Bands (100): | (6.68 - 8.78) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.73 | Sell |
Relative Strength Index (14 RSI): | 52.05 | Buy |
Chaikin Money Flow: | 407425 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.94 - 126.18) | Buy |
Bollinger Bands (100): | (121.79 - 147.11) | Sell |
SLDB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.56 | Buy |
20-day SMA: | 6.96 | Buy |
50-day SMA: | 7.79 | Sell |
200-day SMA: | 8.67 | Sell |
8-day EMA: | 6.61 | Buy |
20-day EMA: | 6.92 | Buy |
50-day EMA: | 7.48 | Sell |
200-day EMA: | 7.78 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.05 | Buy |
20-day SMA: | 123.19 | Buy |
50-day SMA: | 129.3 | Sell |
200-day SMA: | 129.37 | Sell |
8-day EMA: | 123.31 | Buy |
20-day EMA: | 123.92 | Buy |
50-day EMA: | 128.34 | Sell |
200-day EMA: | 127.83 | Sell |
Solid Biosciences Earnings Growth & SLDB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and an increase next year of $0.14 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.28 per share, and an increase next year of $9.02 per share.
Solid Biosciences Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |